Kaplan Matthew L.
Nuvectis Pharma, Inc. · Director
Kaplan Matthew L. is listed in public filings as director. This Kaplan Matthew L. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nuvectis Pharma, Inc. (NVCT). Investors use Kaplan Matthew L.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $729k124.8k shares | BuyNov 5, 2025 | $64.2K11k shares | $5.84 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --113.8k shares | Grant / ExerciseJun 12, 2025 | Disclosure amount unavailable30k shares | -- | -- | |
| --83.8k shares | Grant / ExerciseJun 13, 2024 | Disclosure amount unavailable30k shares | -- | -- |